🧠 Shape-Memory Polymer Stent Deployment Simulator

Programming the Temporary Shape

Before it ever reaches a patient, the stent is heated above its transition temperature, formed into an expanded lattice cylinder, then cooled while compressed onto the catheter shaft — mechanically locking in a temporary, low-diameter shape.

• 35°C: Transition temp (Ttrans) (engineered just below body temp)
• 6–24 mo: Degradation window (polymer-dependent)
• 0%: Recovery ratio (not yet triggered)
• 0 kPa: Radial force (compressed, inert)

Programming cycle

The stent is fabricated at full diameter, heated above Ttrans to become rubbery, mechanically compressed onto the catheter, and cooled below Ttrans while held in compression. The polymer chains freeze into this strained, temporary configuration — a process called shape programming.

Material system

Biodegradable shape-memory polymers are typically PLA/PCL (polylactic acid / polycaprolactone) copolymer networks. Crystalline or glassy "switching" segments lock the temporary shape, while covalent or physical netpoints "remember" the original expanded geometry.

Storage stability

Because Ttrans sits close to but below 37°C, the compressed shape is stable at room temperature and during cold-chain storage — the stent will not prematurely deploy before it reaches the patient.

Unlike Nitinol self-expanding stents, which rely on a temperature-driven martensite–austenite phase transformation in a metal alloy, SMP stents store and release strain energy through polymer chain network mechanics — a fundamentally different physical mechanism that also enables full biodegradability.

Transit Through the Vasculature

The compressed stent, still locked below its transition temperature, is advanced through a catheter sheath along the vascular or airway pathway toward the lesion — its small profile minimizing trauma during transit.

• 35°C: Transition temp (Ttrans) (not yet reached)
• 1.8 mm: Crimped diameter (catheter-compatible)
• 0%: Recovery ratio (shape still locked)
• 0 kPa: Radial force (no wall contact)

Low-profile advantage

A small crimped profile allows the delivery system to navigate tortuous, narrowed, or pediatric-scale vessels and airways that would not accommodate a bulkier balloon-expandable metal platform.

Thermal isolation

Ambient body warmth near the catheter shaft is normally insufficient to trigger premature expansion, since the polymer is engineered with a sharp transition just under 37°C and the compressed segment is largely shielded within the sheath.

Imaging guidance

Radiopaque markers embedded in the stent or catheter tip let the interventionalist track position under fluoroscopy or endoscopy throughout the delivery pathway.

Targeting the Lesion

With the catheter tip aligned across the stenosis or collapsing segment, the outer restraining sheath is withdrawn, exposing the compressed stent while it is still below its transition temperature.

• 35°C: Transition temp (Ttrans) (warming begins)
• 2.0 mm: Working diameter (sheath just released)
• 15%: Recovery ratio (early relaxation)
• 4 kPa: Radial force (minimal wall contact)

Sheath withdrawal

Retracting the outer sheath removes the mechanical constraint holding the stent compressed. Blood or airway humidity at close to body temperature begins conducting heat into the polymer struts.

Precise placement

Because expansion is not instantaneous, clinicians have a short working window to fine-tune stent position before the lattice locks into its final expanded geometry — an advantage over instantly-deploying platforms.

Early recovery

A small amount of shape recovery begins immediately as the outermost struts contact warm blood, gently seating the stent against the vessel wall before full thermal equilibrium is reached.

Self-Expansion to Full Diameter

As the polymer equilibrates to 37°C body temperature, it crosses its transition temperature and softens; the elastic strain stored during programming drives the lattice to recover its original expanded diameter, gently but firmly opening the vessel or airway.

• 37°C: Body temperature (trigger reached)
• 85–98%: Recovery ratio (near-full recovery)
• 35 kPa: Radial force (therapeutic range)
• 1–3 min: Expansion time (gradual, controllable)

No balloon required

Unlike balloon-expandable metal stents, which need mechanical over-pressure from an inflated balloon to plastically deform the metal, the SMP stent expands from its own stored elastic energy once warmed — eliminating a step of the procedure and the associated barotrauma risk.

Recovery ratio

Recovery ratio describes how close the deployed diameter comes to the fully programmed target shape. High-fidelity SMP formulations reliably reach 85–98% recovery in vivo, with the remainder recoverable creep occurring over the following hours.

Radial force delivery

Radial force — the outward pressure exerted against the vessel or airway wall — builds progressively as the lattice unfolds, reaching a therapeutic plateau sufficient to resist elastic recoil of the diseased tissue without overstressing the wall.

Platform comparison

Each platform trades off delivery mechanism, permanence, and radial strength differently — SMP stents are distinguished by combining a low-profile, gentle thermal deployment with true biodegradability.

Scaffolding, Then Disappearing

At full radial force the stent holds the vessel or airway patent through the healing phase. Over the following months, hydrolytic degradation of the PLA/PCL backbone gradually weakens and thins the struts as the surrounding tissue takes over mechanical support.

• 35–42 kPa: Radial force (peak) (sustained scaffolding)
• ~3 mo: Mass loss onset (hydrolysis begins)
• 6–24 mo: Full resorption (matched to healing)
• 100%: Recovery ratio (fully deployed)

Matching degradation to healing

The degradation timeline is tuned via polymer molecular weight, crystallinity, and copolymer ratio so that mechanical scaffolding persists only as long as the vessel or airway needs it — typically 6 to 24 months depending on the clinical indication.

Hydrolytic erosion

Ester bonds in the PLA/PCL backbone are cleaved by water, progressively lowering molecular weight, then strut cross-section, until the lattice loses mechanical integrity and is cleared as lactic acid and other resorbable byproducts.

Avoiding late complications

Because no permanent metal cage remains, the risks associated with lifelong foreign-body presence — late stent thrombosis, chronic inflammation, restricted future vessel growth, and the need for a second removal procedure — are avoided entirely.

This is especially valuable in pediatric vascular and airway stenting, where a permanent, non-degradable implant like Nitinol cannot expand with a growing child and may eventually require surgical removal or replacement.